Vectura Group (VEC)

Sector: Pharma and Biotech     Index: FTSE 250
0.10%
0.10p
100.30p
17:17 22/09/17
100.30p
17:17 22/09/17
DAILY VARIATION
0.10%
0.10p
VOLUME
704,283
REAL TIME BATS
100.30p
17:36 22/09/17
-0.30%
-0.30p
DATA
52 Week High
163.00p
52 Week Low
89.95p
Shares Issued
679.34m
Market Cap
£681.38m
RiskGrade
222
Beta
0.48
MENU

Vectura Group Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -35.2% -42.1%
ROCE 0.0%
Latest F'cast
P/E 13.5 32.3
PEG 0.4 -0.5
Pr/Revenue 4.1 4.2
Pr/Book 1.0
Latest F'cast
Revenue 133.2% -15.0%
PBT 0.0% n/a
EPS 30.4% -50.8%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2013-03-31 30.50 -10.40 -1.80p -50.4 0.0 n/a n/a 0.0%
2014-03-31 36.50 -4.80 1.50p 102.2 0.0 n/a n/a 0.0%
2015-03-31 58.00 -6.20 4.00p 36.4 0.2 167% n/a 0.0%
2016-03-31 72.00 -1.90 5.70p 28.5 0.7 42% n/a 0.0%
2016-12-31 126.50 -40.10 7.43p 18.4 0.6 30% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 157.56 -66.39 3.18p 32.3 -0.6 -57% 0.00p 0.0%
2018-12-31 189.85 -49.65 4.26p 24.4 0.7 34% 0.00p 0.0%

Regulatory News

slide to see more
Holding(s) in Company 22-Sep-17 17:06
Holding(s) in Company 18-Sep-17 13:20
Director/PDMR Shareholding 13-Sep-17 09:45

Newspaper Links

No results found